CVS Health’s operating will take up to a $1 billion hit in 2024 for the reason that low Medicare Benefit star ratings, the corporation mentioned in a Securities and Exchange Commission (SEC) filing now.
Just 21% of the persons in the company’s Medicare Benefit plans have been in plans with 2023 star rating of four. or higher compared with 87% in the 2022 star ratings, the SEC filings mentioned.
The Centers of Medicare and Medicaid Solutions (CMS) makes use of its star ratings to establish which Medicare Benefit plans qualify for high-quality bonuses. Plans with a rating of four. or far more can acquire the high-quality bonuses to their premiums
The CVS’ 2024 operating revenue is impacted by the 2023 ratings for the reason that CMS makes use of the 2023 ratings to establish eligibility for the 2024 bonuses.
Modern day Healthcare was the initially to report on the SEC filing.
The star ratings are primarily based on measurements of Medicare Advantage’s coverage of preventive care and chronic illness management as nicely as buyer satisfaction.
In the SEC filing, CVS mentioned the major driver of the precipitous drop in members covered with plans eligible for bonus payments was a 1-star lower in the company’s Aetna National preferred provider organization.
One thought on “CVS Health’s 2024 Operating Revenue Lowered by up to $1 Billion Simply because of Low MA Star Ratings”